CMS proposes the 2026 Physician Fee Schedule, addressing payment disparities in oncology, but warns of financial threats from ...

USTR Commended for Tackling Unfair Pharmaceutical Pricing That Burdens U.S. Consumers and Threatens Innovation A group of ...

A Gastonia, North Carolina, pharmacist has been sentenced for selling more than 1,500 pills without a prescription, according ...

In this second part of a two-part series on dealing with the high price of prescription drugs, experts share their insider ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Tirzepatide could result in net lifetime health care costs of more than $16 trillion in the U.S. if all people eligible to ...

Alexander I. Spira, MD, PhD, of The US Oncology Network, discusses findings from the COCOON trial that show prophylactic ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Employees enrolled in HDHPs are often the most exposed to price volatility, making pharmacy strategy a critical lever in any cost-containment plan.

These three tech giants in Cuban's portfolio are still long-term plays despite incredible gains in the past several years.

9amHealth has a new partnership with Mark Cuban Cost Plus Drugs to help members afford obesity medications.

9amHealth, a leader in complete cardiometabolic care, and Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), today announced a collaboration that will make obesity medications more ...